SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-004339
Filing Date
2022-01-31
Accepted
2022-01-31 06:15:12
Documents
14
Period of Report
2022-01-27
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea154662-8k_bimiinter.htm   iXBRL 8-K 29319
2 EMPLOYMENT AGREEMENT DATED JANUARY 27, 2022 ea154662ex10-1_bimiinter.htm EX-10.1 32675
3 EMPLOYMENT AGREEMENT DATED JANUARY 27, 2022 ea154662ex10-2_bimiinter.htm EX-10.2 32030
  Complete submission text file 0001213900-22-004339.txt   289784

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bimi-20220127.xsd EX-101.SCH 3027
5 XBRL LABEL FILE bimi-20220127_lab.xml EX-101.LAB 35156
6 XBRL PRESENTATION FILE bimi-20220127_pre.xml EX-101.PRE 23025
8 EXTRACTED XBRL INSTANCE DOCUMENT ea154662-8k_bimiinter_htm.xml XML 3929
Mailing Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100
Business Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100 (8604) 1182209211
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 22571135
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries